AbbVie

ABBV

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

Date	Type	Insider	Position	Ø-Price	Volume
8/14/2026	Sell	Donoghoe, Nicholas	EVP, CHIEF BUS/STRAT OFFICER	$250.0	$8,177,500
3/4/2026	Sell	Purdue, David Ryan	SVP, Controller	$233.6	$1,221,519
3/2/2026	Sell	Siatis, Perry C.	EVP, GC AND SECRETARY	$234.5	$4,375,549
2/25/2026	Sell	Siatis, Perry C.	EVP, GC AND SECRETARY	$230.0	$5,147,630
8/12/2025	Sell	Saleki-Gerhardt, Azita	EVP, CHIEF OPERATIONS OFFICER	$198.4	$8,407,055
8/5/2025	Sell	Donoghoe, Nicholas	EVP, CHIEF BUS/STRAT OFFICER	$198.4	$2,639,253
3/31/2025	Sell	Stewart, Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	$210.0	$12,359,504
3/14/2025	Sell	Reents, Scott T.	EVP, CHIEF FINANCIAL OFFICER	$212.3	$3,746,527
3/3/2025	Sell	Siatis, Perry C.	EVP, GC AND SECRETARY	$210.0	$3,781,680
3/3/2025	Sell	Gonzalez, Richard A.	Director	$210.5	$1,298,549
3/3/2025	Sell	Richmond, Timothy J.	EVP, CHIEF HR OFFICER	$210.6	$4,472,039
2/28/2025	Sell	Siatis, Perry C.	EVP, GC AND SECRETARY	$206.4	$2,040,722
2/28/2025	Sell	Gonzalez, Richard A.	Director	$205.1	$18,964,471
2/26/2025	Sell	Richmond, Timothy J.	EVP, CHIEF HR OFFICER	$202.9	$6,070,036
2/26/2025	Sell	Buckbee, Kevin K.	SVP, CONTROLLER	$203.4	$3,853,373
2/20/2025	Sell	Siatis, Perry C.	EVP, GC AND SECRETARY	$197.8	$1,143,453
12/16/2024	Sell	Buckbee, Kevin K.	SVP, CONTROLLER	$172.2	$310,032